PubRank

Philippe Charron

Author PubWeight™ 70.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2007 6.34
2 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013 6.17
3 Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003 5.85
4 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014 5.21
5 Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013 3.50
6 Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 2012 2.28
7 Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J 2005 2.07
8 Isolated left ventricular non-compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry. Eur J Heart Fail 2010 2.04
9 Genome of an arbuscular mycorrhizal fungus provides insight into the oldest plant symbiosis. Proc Natl Acad Sci U S A 2013 1.94
10 A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 2011 1.67
11 Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging. Eur Heart J 2010 1.53
12 Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace 2010 1.40
13 Contraction delay of the RV outflow tract in patients with Brugada syndrome is dependent on the spontaneous ST-segment elevation pattern. Heart Rhythm 2011 1.39
14 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. Rev Esp Cardiol (Engl Ed) 2015 1.39
15 Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet 2010 1.37
16 Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. Cardiovasc Res 2007 1.21
17 Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J 2009 1.19
18 Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum Mol Genet 2012 1.16
19 Natural history of Barth syndrome: a national cohort study of 22 patients. Orphanet J Rare Dis 2013 1.11
20 Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2012 1.11
21 Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy. J Am Coll Cardiol 2012 1.01
22 Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease. Muscle Nerve 2006 1.00
23 A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Res 2009 0.97
24 Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study. Heart 2010 0.92
25 A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J 2013 0.92
26 Extreme diversification of the mating type-high-mobility group (MATA-HMG) gene family in a plant-associated arbuscular mycorrhizal fungus. New Phytol 2013 0.89
27 [2015 ESC Guidelines for the diagnosis and management of pericardial diseases]. Kardiol Pol 2015 0.89
28 Expanding the phenotype associated with a desmoplakin dominant mutation: Carvajal/Naxos syndrome associated with leukonychia and oligodontia. Int J Cardiol 2012 0.87
29 Functional characterization of the cAMP-binding proteins Epac in cardiac myocytes. Pharmacol Rep 2009 0.87
30 Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 2012 0.87
31 A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity. Eur J Heart Fail 2012 0.86
32 High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study. Neuromuscul Disord 2011 0.85
33 Mutational analysis of the beta- and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy. Am J Med Genet A 2003 0.84
34 FHL2 expression and variants in hypertrophic cardiomyopathy. Basic Res Cardiol 2014 0.84
35 Brugada ECG pattern: a physiopathological prospective study based on clinical, electrophysiological, angiographic, and genetic findings. Front Physiol 2012 0.82
36 Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathy. Eur Heart J 2005 0.81
37 Screening of genes encoding junctional candidates in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Europace 2013 0.80
38 Structures of the lamin A/C R335W and E347K mutants: implications for dilated cardiolaminopathies. Biochem Biophys Res Commun 2012 0.79
39 CardioPulse Articles. Eur Heart J 2015 0.79
40 Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy. J Am Coll Cardiol 2012 0.79
41 Desmosomal cadherins are decreased in explanted arrhythmogenic right ventricular dysplasia/cardiomyopathy patient hearts. PLoS One 2013 0.78
42 'Ten Commandments' of 2015 ESC Guidelines for diagnosis and management of pericardial diseases. Eur Heart J 2015 0.77
43 Brugada syndrome in pure black Africans. J Cardiovasc Electrophysiol 2007 0.77
44 Genetic analysis for predictive screening in hypertrophic cardiomyopathy. Heart 2012 0.77
45 [Idiopathic cardiomyopathies]. Rev Prat 2002 0.77
46 Advising a cardiac disease gene positive yet phenotype negative or borderline abnormal athlete: is sporting disqualification really necessary? Br J Sports Med 2012 0.76
47 Cardiac device implantation in Fabry disease: A retrospective monocentric study. Medicine (Baltimore) 2016 0.75
48 Reversible Severe Eosinophilic Endomyocardial Fibrosis During Pregnancy: A Case Report. Medicine (Baltimore) 2015 0.75
49 Heritable disease and sperm donation. JAMA 2010 0.75
50 Sporadic arrhythmogenic right ventricular cardiomyopathy/dysplasia due to a de novo mutation. Europace 2009 0.75
51 [2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome) 2015 0.75
52 [Classification of the cardiomyopathies]. Kardiol Pol 2008 0.75
53 'Ten Commandments' of 2015 ESC Guidelines for diagnosis and management of pericardial diseases. Eur Heart J 2015 0.75
54 A new scoring system for the triage of cardiac tamponade. Expert Rev Cardiovasc Ther 2015 0.75
55 What's new in 2015 ESC guidelines on pericardial diseases? J Cardiovasc Med (Hagerstown) 2016 0.75